Human CCL22 / MDC Protein, Fc Tag

사용자 리뷰
제품 번호/규격
가격
수량
CC2-H5257-20ug
$185.00
CC2-H5257-50ug
$370.00
CC2-H5257-1mg
$3400.00
ETA of in-stock products:2 business days
총 항목 수 제품 금액$ 0

제품 세부정보

  • Synonyms

    MDC, ABCD-1, SCYA22, STCP-1, DC, B-CK, A-152E5.1

  • Source

    Human CCL22, Fc Tag (CC2-H5257) is expressed from human 293 cells (HEK293). It contains AA Gly 25 - Gln 93 (Accession # O00626-1).

    Predicted N-terminus: Gly 25

    Request for sequence
  • Molecular Characterization

    CCL22 Structure

    Other Tags and Version Biotin & Other Labeled Version

    This protein carries a human IgG1 Fc tag at the C-terminus.

    The protein has a calculated MW of 34.5 kDa. The protein migrates as 35-40 kDa under reducing (R) condition (SDS-PAGE) due to glycosylation.

  • Endotoxin

    Less than 1.0 EU per μg by the LAL method / rFC method.

  • Purity

    >95% as determined by SDS-PAGE.

  • Formulation

    Lyophilized from 0.22 μm filtered solution in PBS, 0.2 M Arginine, pH7.4 with trehalose as protectant.

    Contact us for customized product form or formulation.

  • Reconstitution

    Please see Certificate of Analysis for specific instructions.

    For best performance, we strongly recommend you to follow the reconstitution protocol provided in the CoA.

  • Storage

    For long term storage, the product should be stored at lyophilized state at -20°C or lower.

    Please avoid repeated freeze-thaw cycles.

    This product is stable after storage at:

    1. -20°C to -70°C for 12 months in lyophilized state;
    2. -70°C for 3 months under sterile conditions after reconstitution.
  • ACRO Quality Management System

    1. QMS(ISO, GMP)
    2. Quality Advantages
    3. Quality Control Process

고객님도 확인한 상품

데이터 표시

  • SDS-PAGE

    CCL22 SDS-PAGE

    Human CCL22, Fc Tag on SDS-PAGE under reducing (R) condition. The gel was stained with Coomassie Blue. The purity of the protein is greater than 95%.

사용자 리뷰
댓글 남기기

배경 소개

MDC is the high-affinity ligand for CCR4. Secreted by tumor-associated macrophages and dendritic cells, CCL22 recruits immunosuppressive CCR4+ Tregs into the tumor microenvironment. This chemokine axis dampens anti-tumor immunity, and its blockade aims to exclude Tregs and unleash effector T-cell responses.

프론티어 진행

 
의약품 개발 진행
  • 영어 이름:

    ATP Binding Cassette Subfamily D Member 1

  • 카테고리:

  • 상장 의약품 수:

    1 상세

  • 임상 의약품 수:

    2 상세

  • 최고 개발 단계:

    Approved

연락하기
신약 후보물질 라이선싱
더 많이 알아보기
  • 기본 제품 정보
  • 제품 세부정보
  • 고객님도 확인한 상품
  • 데이터 표시
  • 사용자 리뷰
  • 배경
문의하기

전화
글로벌: +1 800-810-0816 (무료)
아시아태평양: +86 400-682-2521

주소 서울특별시 송파구 법원로11길 11, 제3층 제비-314,315호